Ex-vivo whole blood cultures for predicting cytokine-release syndrome: Dependence on target antigen and antibody isotype

Therapeutic Immunology

Volumn 2, Issue 4, 1995, Pages 183-190

  Wing, M G ^a   Waldmann, H ^a   Isaacs, J ^a   Compston, D A S ^a   Hale, G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Antigen; Blood; Cytokines; Human; Isotype; Serotherapy

Indexed keywords

ALEMTUZUMAB; ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD52 ANTIGEN; CYTOKINE; ENDOTOXIN; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 6; MONOCLONAL ANTIBODY; POLYMYXIN B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; ASSAY; BLOOD CULTURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNDROME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, CD; ANTIGENS, NEOPLASM; ARTHRITIS, RHEUMATOID; BLOOD CELLS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; POLYMYXIN B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029429152     PISSN: 09670149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)